Human Trial Shows Cannabidiol Reduces Seizures in Kids With Severe Form of Epilepsy

by DailyHealthPost Editorial

Years of anecdotal evidence showing the benefits of cannabidiol (CBD) in reducing the frequency of seizures in adults and children alike have finally been confirmed by a clinical trial. CBD oil, while sourced from the marijuana plant, does not have any mind-altering effects.

Published in a recent issue of the New England Journal of Medicine, the randomized trial focused on children with Dravet syndrome. Dravet syndrome is a severe form of epilepsy that begins in infancy and is often fatal. The result of a genetic mutation, it is extremely resistant to conventional seizure medications.

In the study, 120 patients were divided into two groups: CBD and control (placebo). Over the course of 12 weeks, patients receiving the CBD treatment experienced a reduction of over 12 seizures per month to less than 6, on average.


For many parents, this represents a “last hope”, as some of their children have been on 10 or more different seizure medications and combinations with little-to-no improvement.

Prior to this trial, parents have reported as much as a 90% decrease in seizures in their children with Dravet syndrome by using CBD oil.

source: CBC